Lacosamide clinical trials
Also written Vimpat and SPM 927.
How each study uses Lacosamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Lacosamide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 28 Oct 2008 · VIMPAT · NDA 022253 (FDA, Drugs@FDA)
- European Union
- 29 Aug 2008 · Vimpat · EMEA/H/C/000863 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
91 studies that test it; most in 2004 (10)
| Year | Studies |
|---|---|
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 10 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 8 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 59 · Other 32
UCB Pharma (32) · UCB BIOSCIENCES, Inc. (12) · UCB Biopharma S.P.R.L. (4) · Kafrelsheikh University (3) · UCB Pharma SA (3) · UCB BIOSCIENCES GmbH (3) · UCB Biopharma SRL (2) · Le Bonheur Children's Hospital (2)
Often tested with
Tested in the same studies.
Levetiracetam (7) · Phenobarbital (3) · Pregabalin (2) · Topiramate (2) · Valproic Acid (2) · Propranolol (1) · Fosphenytoin (1) · Phenytoin (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3, 1 in phase 3
Studies that test Lacosamide, phase 3 first.
- Jan 2027Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.Phase 3 · University of Sao Paulo
- Mar 2027STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic PancreatitisPhase 1 · Indiana University
- Apr 2027Seizure Prevention in Traumatic Brain Injury With Levetiracetam and LacosamidePhase 4 · Wake Forest University Health Sciences
Studies
Open first, then newest update. How each study uses Lacosamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 91
- Seizure Prevention in Traumatic Brain Injury With Levetiracetam and LacosamideRecruitingPhase 4Wake Forest University Health SciencesNCT06866691Written as lacosamide
- Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.RecruitingPhase 3University of Sao PauloNCT07412132Written as Lacosamide
- Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic NeuralgiaRecruitingNot applicableCMH Kharian Medical CollegeNCT06969417Written as Lacosamide
- Lacosamide Versus Topiramate in MigraineRecruitingPhase 3Kafrelsheikh UniversityNCT06243692Written as Lacosamide 50 MG
- Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With EpilepsyRecruitingPhase 4Xiangya Hospital of Central South UniversityNCT05969054Written as Lacosamide 100 mg
- STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic PancreatitisActive, not recruitingPhase 1Indiana UniversityNCT05603702Written as Lacosamide
- Add on Lacosamide Versus High Dose MonotherapyCompletedPhase 3Brigham and Women's HospitalNCT01345058Written as lacosamide
- Antiseizure Medication in Seizure Networks at Early Acute Brain InjuryTerminatedPhase 4University of North Carolina, Chapel HillNCT06081283Written as Lacosamide Injectable Product
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal SeizuresTerminatedPhase 2UCB Biopharma SRLNCT04519645Written as Lacosamide intravenous
- A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide TreatmentCompletedPhase 3UCB Biopharma SRLNCT04627285Written as Lacosamide
- Combined Effect of Pregabalin and Oxycodone, and Lacosamide and Oxycodone, on BreathingCompletedPhase 4Leiden University Medical CenterNCT05598905Written as Lacosamide 150 mg
- Lacosamide Versus Propranolol in MigraineCompletedPhase 3Kafrelsheikh UniversityNCT05851781Written as Lacosamide tablet
- A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).CompletedPhase 2UCB PharmaNCT00861068Written as SPM927/Lacosamide
- A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic NeuropathyCompletedPhase 3UCB PharmaNCT00350103Written as SPM 929
- The Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine PatientsCompletedPhase 3Kafrelsheikh UniversityNCT05632133Written as Lacosamide 50 MG Oral Tablet
- An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic NeuropathyCompletedPhase 2UCB PharmaNCT00861042Written as SPM927/Lacosamide
- Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic SeizuresCompletedPhase 3UCB BIOSCIENCES, Inc.NCT02408549Written as Lacosamide Tablet
- Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.CompletedPhase 3UCB PharmaNCT00546351Written as Lacosamide
- A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic NeuropathyCompletedPhase 3UCB PharmaNCT00220337Written as Lacosamide
- A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994CompletedPhase 3UCB Biopharma S.P.R.L.NCT02582866Written as Lacosamide
See all 91 studies that test Lacosamide →
Given beside what is tested · 1 — Lacosamide is usual care or a partner of the new treatment
Codes
What other systems call Lacosamide · ClinicalTrials.gg INT006830
- MeSH (NLM) D000078334LacosamideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 563KS2PQY5LACOSAMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 623400Confirmed FDA, Wikidata
- Wikidata Q420077lacosamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C83859LacosamideOne source FDA
- DrugBank DB06218One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078334 | Lacosamide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 563KS2PQY5 | LACOSAMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 623400 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420077 | lacosamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C83859 | Lacosamide | One source FDA |
| DrugBank | DB06218 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.